Neurorehabilitation Devices Market Worth $3.2 Billion By 2024: Grand View Research, Inc.

Oct 04, 2016, 06:14 ET from Grand View Research, Inc.

SAN FRANCISCO, October 4, 2016 /PRNewswire/ --

The global neurorehabilitation devices market in 2015 was valued at USD 915.1 million and is estimated to reach USD 3.2 billion by 2024. Around 1 billion people are suffering from neurological disorders across the globe. These neurological disorders are resulting in increased movement disabilities. The increasing prevalence of movement disability, attributed to various neurological disorders (multiple sclerosis, stroke, etc) along with need for comprehensive management is the key factors driving the market growth.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757)

Every year around 15 million people suffer from stroke globally, of which 5 million people are affected by permanent disability. Each year Multiple sclerosis and Parkinson's disease affect 2.5 million and 10 million patients respectively worldwide. The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.

Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector. Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.

Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.

Browse full research report with TOC on "Neurorehabilitation Devices Market By Products (Neurorobotics, Brain-Computer Interface, Wearable Devices, Noninvasive Stimulators), By Therapy Area (Stroke, Multiple Sclerosis, Parkinson's Disease, Cerebral Palsy, Others - Brain And Spinal Cord Injury), And Segment Forecasts To 2024" at: http://www.grandviewresearch.com/industry-analysis/neurorehabilitation-devices-market

Further Key Findings from the Study Suggest: 

  • Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
  •  Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
  • Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic's brain stimulation therapy in the treatment of Parkinson's disease.

Grand View Research has segmented the neurorehabilitation devices market by products, therapy area, and region: 

  • Products Outlook (Market revenue in USD Million, 2013 - 2024) 
    • Neurorobotics
    • Brain-computer interface
    • Wearable devices
    • Non-invasive Stimulators
  • Therapy Area Outlook (Market Revenue in USD Million, 2013 - 2024) 
    • Stroke
    • Multiple Sclerosis
    • Parkinson's Disease
    • Cerebral Palsy
    • Others
  • Regional Outlook (Market Revenue in USD Million, 2013 - 2024) 
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • Middle East and Africa
      • South Africa

 Browse related reports by Grand View Research: 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - legalworkshop.org, grandviewresearch.com/blogs/healthcare

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com  

SOURCE Grand View Research, Inc.